Dr. Abramson Discusses TRANSCEND in Relapsed/Refractory B-Cell Lymphomas
June 8th 2018Jeremy Slade Abramson, MD, clinical director, Center for Lymphoma, Massachusetts General Hospital, discusses the updated results of the TRANSCEND study in patients with relapsed/refractory b-cell lymphomas.
Read More